Stay updated on BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Sign up to get notified when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.
Latest website image capture
Clouds background image

Latest updates to the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:43:37.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:27:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to include specific drug information for Tislelizumab and has revised location details, including the addition of South Korea and Taiwan locations. The revision number has also been updated to v3.0.0.
    Difference
    5%
    Check dated 2025-08-30T12:16:07.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:51:44.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T00:22:22.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-01T19:35:59.000Z thumbnail image

Stay in the know with updates to BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Enter your email address, and we'll notify you when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.